Advertisement

Topics

Pancreatic Cancer Action Network Company Profile

17:13 EDT 24th September 2017 | BioPortfolio

The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization raises money for direct private funding of research -- and advocates for more aggressive federal research funding of medical breakthroughs in prevention, diagnosis and treatment of pancreatic cancer.


News Articles [6640 Associated News Articles listed on BioPortfolio]

Wage Hope at PurpleStride San Francisco, the Walk to End Pancreatic Cancer

PurpleStride supports the Pancreatic Cancer Action Network, the national organization dedicated to fighting the world’s toughest cancer The Pancreatic Cancer

Increased Clinical Trial Participation Needed To Improve Survival Of Pancreatic Cancer, The Fourth Leading Cause Of Cancer Death In The United States

MANHATTAN BEACH, Calif., Jan. 8, 2013 /PRNewswire/ --January is National Pancreatic Cancer Clinical Trials Awareness Month and as part of this initiative, the Pancreatic Cancer Action Network is calli...

PurpleStride Milwaukee to Raise Funds, Awareness for Nation’s Toughest Cancer

Join WISN 12’s Sally Severson at PurpleStride, the walk to end pancreatic cancer The Pancreatic Cancer Action Network’s Milwaukee Affiliate invites everyone to ...

Pancreatic Cancer Action Network Invests in Precision Medicine and Early Detection to Change Outcomes for the World’s Toughest Cancer

The Pancreatic Cancer Action Network (PanCAN) is driving research progress by targeting precision medicine and early detection methods for the world’s toughest cancer. Th...

Pancreatic Cancer Action Network Bolsters Its Distinguished Scientific And Medical Advisory Board

MANHATTAN BEACH, Calif., July 11, 2017 /PRNewswire/ -- The Pancreatic Cancer Action Network (PanCAN), the largest organization tackling the world's toughest cancer, today announced that five national ...

PurpleStride Washington D.C. Aims to Change the Course of Nation’s Toughest Cancer

Funds raised at PurpleStride, the walk to end pancreatic cancer, support vital research and clinical initiatives of the Pancreatic Cancer Action Network The Pancrea

Twin Cities Turns Purple to End Pancreatic Cancer on September 16

MINNEAPOLIS, Aug. 29, 2017 /PRNewswire-USNewswire/ -- The Twin Cities will turn purple as thousands participate in PurpleRideStride Minnesota, the road to end pancreatic cancer on Sept. 16. The commun...

Renewed Research Effort Focuses On "Undruggable" Mutation Found In 95 Percent Of Pancreatic Cancers

MANHATTAN BEACH, Calif., April 6, 2016 /PRNewswire-USNewswire/ -- Nearly all patients diagnosed with pancreatic cancer are found to have a KRAS mutation, part of the RAS family of genes. To bette...

PubMed Articles [12200 Associated PubMed Articles listed on BioPortfolio]

Treatment of pancreatic insufficiency using pancreatic extract in patients with advanced pancreatic cancer: a pilot study (PICNIC).

Survival with advanced pancreatic cancer is less than 12 months. Pancreatic exocrine insufficiency may contribute to pancreatic cancer-related cachexia, via nutrient malabsorption. We aimed to determ...

KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway.

Pancreatic cancer is highly malignant and characterised by rapid and uncontrolled growth. While some of the important regulatory networks involved in pancreatic cancer have been determined, the cancer...

MicroRNA‑296 targets AKT2 in pancreatic cancer and functions as a potential tumor suppressor.

Although microRNA-296 (miR-296) has been studied in various types of human cancer, its expression, biological role and mechanism of action in pancreatic cancer remains to be elucidated. The aim of the...

The clinical value, regulatory mechanisms, and gene network of the cancer-testis gene STK31 in pancreatic cancer.

We aimed to identify STK31 as a cancer-testis (CT) gene and to explore its potential clinical value, regulatory mechanisms, and gene network in pancreatic cancer (PC). Gene expression data were genera...

Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.

Genetic alterations in K-ras and p53 are thought to be critical in pancreatic cancer development and progression. However, K-ras and p53 expression in pancreatic adenocarcinoma have not been systemati...

Clinical Trials [8565 Associated Clinical Trials listed on BioPortfolio]

Pancreatic Cancer Registry: For Any Person With a Personal or Family History

The NFPTR was established in 1994 to find the causes of pancreatic cancer. In brief, the investigators are interested in both the genetic and non-genetic causes of pancreatic cancer. The i...

Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue

Pancreatic cancer is a very aggressive cancer. Over the past 40 years there has not been much progress made in reducing deaths from this cancer. Recently, new models of pancreatic cancers ...

Local Invasion of Pancreatic Cancer

Pancreatic cancer often spreads through local invasion into local structures, including fat, blood vessels, nerves, and nearby organs (stomach, duodenum, spleen, bile duct). Local microsco...

Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer

To assess the response for subjects with pancreatic cancer that have undergone surgical resection and treatment with a vaccine given with or without chemotherapy and chemoradiation.

Optimizing the Efficacy of Multimodality Therapies for Pancreatic Cancer

This is an observational, prospective and retrospective registry of patients with pancreatic cancer treated in Duke University Health System, which will examine patient and treatment effec...

Companies [2251 Associated Companies listed on BioPortfolio]

Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organizat...

Pancreatic Cancer Action

About Pancreatic Cancer Action: 5 year survival rates for pancreatic cancer have not changed in over 40 years and it is our mission to change this by way of increased awareness of pancreatic cancer...

World Pancreatic Cancer Coalition

The World Pancreatic Cancer Coalition is an international group of pancreatic cancer patient advocacy groups with a mission to drive transformational change for all those affected...

Sky Foundation, Inc.

After being diagnosed with pancreatic cancer in 2007 and responding well to treatment, Kasselman established Sky Foundation to fund research for the Sky Foundation Pancreatic Cancer Research Fund at t...

Corporate Action Network

Corporate Action Network was founded to address the imbalance of power between corporations and people. Using the new tools of the Action Network and a networked approach, Corpora...

More Information about "Pancreatic Cancer Action Network" on BioPortfolio

We have published hundreds of Pancreatic Cancer Action Network news stories on BioPortfolio along with dozens of Pancreatic Cancer Action Network Clinical Trials and PubMed Articles about Pancreatic Cancer Action Network for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pancreatic Cancer Action Network Companies in our database. You can also find out about relevant Pancreatic Cancer Action Network Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record